4.6 Review

COVID-19 vaccination in pregnancy

期刊

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.ajog.2022.05.020

关键词

antibodies; COVID-19; immunogenicity; maternal immunization; pandemic; pregnancy; reactogenicity; SARS-CoV-2; side effects; vaccine

向作者/读者索取更多资源

Despite official and professional endorsements, pregnant individuals still exhibit vaccine hesitancy towards COVID-19 vaccination. Accumulated evidence highlights that pregnant individuals are at special risk for COVID-19 with increased risks of severe complications. However, vaccination reduces these risks and does not pose harm to pregnancy or newborns. Observational studies and data from vaccinated individuals indicate that immunization with mRNA vaccines is safe and highly effective in preventing severe COVID-19 infections in pregnant individuals. Ensuring unrestricted access to COVID-19 vaccination for pregnant individuals should be a global priority.
Despite a recent endorsement from official and professional bodies unequivocally recommending COVID-19 vaccination, vaccine hesitancy among pregnant people remains high. The accumulated evidence demonstrates that pregnant people are a special risk group for COVID-19, with an increased risk of intensive care unit admission, extracor-poreal membranous oxygenation requirement, preterm birth, and perinatal death. These risks are further increased with some variants of concern, and vaccination of pregnant people reduces the COVID-19-related increase in maternal or fetal morbidity. Data from more than 180,000 vaccinated persons show that immunization against COVID-19 with an mRNA vaccine is safe for pregnant people. Many observational studies comparing perinatal outcomes between vaccinated and unvaccinated pregnant people have had reassuring findings and did not demonstrate harmful effects on pregnancy or the newborn. Immunization with mRNA vaccines does not increase the risk of miscarriage, preterm delivery, low birthweight, maternal or neonatal intensive care unit admission, fetal death, fetal abnormality, or pulmonary embolism. Moreover, observational data corroborate the findings of randomized trials that mRNA vaccination is highly effective at preventing severe SARS-CoV-2 infection in pregnant people, emphasizing that the potential maternal and fetal benefits of vaccination greatly outweigh the potential risks of vaccination. Ensuring pregnant people have unrestricted access to COVID-19 vaccination should be a priority in every country worldwide.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据